STUDY OBJECTIVES: There are few data on the effects of continuous positive airway pressure (CPAP) therapy on the structural and functional characteristics of the right heart in patients with obstructive sleep apnea (OSA). We sought to leverage the advantages of cardiac magnetic resonance imaging (CMR) and hypothesized that CPAP treatment would improve right ventricular (RV) function in a group of patients with OSA who were free of other comorbid conditions. METHODS:Patients with severe (apnea-hypopnea index > or = 30/h) untreated OSAwere prospectively enrolled. CMR included 3-dimensional measurement of biventricular size and function, and rest/stress myocardial perfusion and was performed at baseline and after 3 months of CPAP therapy. RESULTS:Fifteen patients with mild to moderate desaturation were enrolled; 2 could not undergo CMR due to claustrophobia and obesity. There were significant decreases in the Epworth Sleepiness Scale score (p < 0.0001) and RV end-systolic andRV end-diastolic volumes (p < 0.05) with CPAP. There was a trend toward improvement in RV ejection fraction, but the improvement did not reach statistical significance. Other measures such as left ventricular volumes, left ventricular ejection fraction, myocardial perfusion reserve index, and thickness of the interventricular septum and ventricular free wall did not change significantly. CONCLUSIONS: This preliminary study found that CPAP treatment decreases RV volumes in patients with severe OSA who are otherwise healthy. CMR offers a novel technique to determine the effects of CPAP on ventricular structure and function in patients with OSA. A randomized controlled study is needed to confirm the results of our study.
RCT Entities:
STUDY OBJECTIVES: There are few data on the effects of continuous positive airway pressure (CPAP) therapy on the structural and functional characteristics of the right heart in patients with obstructive sleep apnea (OSA). We sought to leverage the advantages of cardiac magnetic resonance imaging (CMR) and hypothesized that CPAP treatment would improve right ventricular (RV) function in a group of patients with OSA who were free of other comorbid conditions. METHODS:Patients with severe (apnea-hypopnea index > or = 30/h) untreated OSAwere prospectively enrolled. CMR included 3-dimensional measurement of biventricular size and function, and rest/stress myocardial perfusion and was performed at baseline and after 3 months of CPAP therapy. RESULTS: Fifteen patients with mild to moderate desaturation were enrolled; 2 could not undergo CMR due to claustrophobia and obesity. There were significant decreases in the Epworth Sleepiness Scale score (p < 0.0001) and RV end-systolic and RV end-diastolic volumes (p < 0.05) with CPAP. There was a trend toward improvement in RV ejection fraction, but the improvement did not reach statistical significance. Other measures such as left ventricular volumes, left ventricular ejection fraction, myocardial perfusion reserve index, and thickness of the interventricular septum and ventricular free wall did not change significantly. CONCLUSIONS: This preliminary study found that CPAP treatment decreases RV volumes in patients with severe OSA who are otherwise healthy. CMR offers a novel technique to determine the effects of CPAP on ventricular structure and function in patients with OSA. A randomized controlled study is needed to confirm the results of our study.
Authors: Yasuyuki Kaneko; John S Floras; Kengo Usui; Julie Plante; Ruzena Tkacova; Toshihiko Kubo; Shin-ichi Ando; T Douglas Bradley Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Darren R Mansfield; N Claire Gollogly; David M Kaye; Meroula Richardson; Peter Bergin; Matthew T Naughton Journal: Am J Respir Crit Care Med Date: 2003-11-03 Impact factor: 21.405
Authors: Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell Journal: N Engl J Med Date: 2002-06-20 Impact factor: 91.245
Authors: Frank Grothues; James C Moon; Nicholas G Bellenger; Gillian S Smith; Helmut U Klein; Dudley J Pennell Journal: Am Heart J Date: 2004-02 Impact factor: 4.749
Authors: Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell Journal: Am J Cardiol Date: 2002-07-01 Impact factor: 2.778
Authors: Muddassir Mehmood; Stephanie A Ambach; Michael D Taylor; John L Jefferies; Subha V Raman; Robin J Taylor; Hemant Sawani; Jacob Mathew; Wojciech Mazur; Kan N Hor; Hussein R Al-Khalidi Journal: Pediatr Cardiol Date: 2016-03-02 Impact factor: 1.655
Authors: Liyue Xu; Brendan T Keenan; David Maislin; Thorarinn Gislason; Bryndís Benediktsdóttir; Sigrun Gudmundsdóttir; Marianna Gardarsdottir; Bethany Staley; Frances M Pack; Xiaofeng Guo; Yuan Feng; Jugal Chahwala; Pritika Manaktala; Anila Hussein; Maheshwara Reddy-Koppula; Zeba Hashmath; Jonathan Lee; Raymond R Townsend; Richard J Schwab; Allan I Pack; Samuel T Kuna; Julio A Chirinos Journal: Hypertension Date: 2021-01-19 Impact factor: 10.190
Authors: Jessie P Bakker; Dimitrios Baltzis; Francesco Tecilazich; Raymond H Chan; Warren J Manning; Tomas G Neilan; Meredith L Wallace; Margo Hudson; Atul Malhotra; Sanjay R Patel; Aristidis Veves Journal: Ann Am Thorac Soc Date: 2020-04
Authors: Adrian Curta; Holger Hetterich; Regina Schinner; Aaron M Lee; Wieland Sommer; Nay Aung; Mihir M Sanghvi; Kenneth Fung; Elena Lukaschuk; Jackie A Cooper; José Miguel Paiva; Valentina Carapella; Stefan Neubauer; Stefan K Piechnik; Steffen E Petersen Journal: Medicina (Kaunas) Date: 2021-05-31 Impact factor: 2.430